Physician profile
David M Rowles
NPI 1205805785
$593.65
in general payments reported to CMS, 2019-2025
9 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.73 · 2021: $44.73 · 2022: $28.48 · 2023: $50.52 · 2024: $190 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.35 |
| Education | $189.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $222.10 | 2024-2025 | Fetroja |
| Viiv Healthcare Company | $113.96 | 2021-2025 | Dovato, Cabenuva |
| Merck Sharp & Dohme LLC | $61.00 | 2023-2024 | Delstrigo, Pifeltro, Dificid |
| Janssen Pharmaceuticals, INC | $56.96 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $43.47 | 2024 | |
| Ferring Pharmaceuticals INC. | $38.47 | 2023-2024 | Rebyota |
| Abbvie INC. | $27.39 | 2025 | |
| Paratek Pharmaceuticals, INC. | $17.57 | 2025 | Nuzyra |
| Allergan, INC. | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rowles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.